| scholarly article | Q13442814 |
| P2093 | author name string | N S Key | |
| B Jilma | |||
| R Bradford | |||
| F C Lin | |||
| E L Hobl | |||
| M J Mooberry | |||
| P2860 | cites work | Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. | Q50125801 |
| Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. | Q54704880 | ||
| Tissue factor expression on platelets is a dynamic event | Q57398744 | ||
| Endotoxin-induced intravascular clotting: the need for granulocytes | Q72302020 | ||
| Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms | Q73926512 | ||
| The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation | Q73971447 | ||
| Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli | Q74213440 | ||
| Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia | Q77459246 | ||
| Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans | Q79248994 | ||
| A coagulation factor VII deficiency protects against acute inflammatory responses in mice | Q79281558 | ||
| Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia | Q79339909 | ||
| Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa | Q84002651 | ||
| No evidence for tissue factor on platelets | Q24634305 | ||
| Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin | Q31144359 | ||
| Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice | Q33728358 | ||
| Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. | Q33815424 | ||
| Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees | Q34119308 | ||
| Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability | Q34469955 | ||
| Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis | Q34635642 | ||
| Racial differences in endotoxin-induced tissue factor-triggered coagulation. | Q34935008 | ||
| Microparticles in hemostasis and thrombosis. | Q35131040 | ||
| Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock | Q35611991 | ||
| Human endotoxemia: a model for mechanistic insight and therapeutic targeting | Q36351664 | ||
| Procoagulant microparticles: disrupting the vascular homeostasis equation? | Q36600785 | ||
| Coagulation interventions in experimental human endotoxemia | Q36673531 | ||
| Circulating Levels of Tissue Factor Microparticle Procoagulant Activity Are Reduced With Antiretroviral Therapy and Are Associated With Persistent Inflammation and Coagulation Activation Among HIV-Positive Patients | Q36930484 | ||
| Human endotoxemia as a model of systemic inflammation | Q37232921 | ||
| Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease | Q37406776 | ||
| Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. | Q38905674 | ||
| Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents. | Q39276352 | ||
| Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. | Q39590400 | ||
| Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans | Q40572712 | ||
| Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. | Q41226362 | ||
| Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody | Q43590664 | ||
| Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia | Q43893846 | ||
| Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study | Q44364012 | ||
| Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects. | Q44814556 | ||
| Elevated levels of thrombin‐generating microparticles in stored red blood cells | Q45117210 | ||
| Microparticle sizing by dynamic light scattering in fresh-frozen plasma. | Q45419947 | ||
| Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation | Q46301727 | ||
| Coagulation activation by lipopolysaccharides | Q46832305 | ||
| Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential | Q47228596 | ||
| Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs | Q47321972 | ||
| High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report | Q47326811 | ||
| Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia | Q47362321 | ||
| Vesicles of variable sizes produced by a rapid extrusion procedure | Q47598175 | ||
| Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. | Q48028694 | ||
| P433 | issue | 5 | |
| P921 | main subject | endotoxemia | Q5832599 |
| P304 | page(s) | 1031-1042 | |
| P577 | publication date | 2016-02-08 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia | |
| P478 | volume | 14 |
| Q58895615 | Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis |
| Q54366716 | Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial. |
| Q54255982 | Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients |
| Q63916932 | Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4 |
| Q38934014 | Elevated hematocrit enhances platelet accumulation following vascular injury. |
| Q47970364 | Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome. |
| Q55002951 | Microfluidic cell sorting: Towards improved biocompatibility of extracorporeal lung assist devices. |
| Q58121058 | Role of extracellular vesicles in the development of sepsis-induced coagulopathy |
| Q89395909 | Sepsis-Associated Coagulopathy |
| Q39378240 | The Ability of Extracellular Vesicles to Induce a Pro-Inflammatory Host Response |
Search more.